Discover 792 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 792
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for
Lupus Erythematosus, Systemic
Location: Tustin CA, Katy TX, Lake Charles LA, Sugar Land TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07438496
Phase 3, Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
for
Immunoglobulin G4 Related Disease
Location: Tustin CA, Red Oak TX, Plano TX, Wichita Falls TX,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07190196
Phase 3, Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Location: Austin TX, Kansas City KS, Kansas City MO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05327114
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
for
Sporadic Inclusion Body Myositis (sIBM),
Location: Austin TX
Sponsor: Austin Neuromuscular Center
Sex: All
Age: 45 - 70+
Code: NCT06479863
Early Phase 1, Recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
for
Myasthenia Gravis
Location: Austin TX, Kansas City KS, O'Fallon IL, Iowa City IA,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06298565
Recruiting
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
for
FSHD
Location: Austin TX, Dallas TX, Kansas City KS, Aurora CO,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 0+
Code: NCT04635891
Recruiting
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Location: Austin TX, San Antonio TX, Chattanooga TN, Tampa FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07294170
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Location: Austin TX, San Antonio TX, Chattanooga TN, Tampa FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07284420
Phase 2, Recruiting
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
for
Myasthenia Gravis
Location: Austin TX, Dallas TX, New Orleans LA, Cordova TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07217587
Phase 3, Recruiting
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
for
Generalized Myasthenia Gravis
Location: Austin TX, Chicago IL, Philadelphia PA, Seattle WA
Sponsor: Amgen
Sex: All
Age: 2 - 17
Code: NCT06987539
Phase 2, Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor